Sign in

CIK 0001299130

  • Accelerated filer

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Sign in to watch
Ticker
PACB
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161590339
Phone
+1 650-521-8000
Business address
1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Former names
PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
  1. 4 Grant or award Director acquired 22,821 shares (grant or award)
  2. 4 Grant or award Director acquired 22,821 shares (grant or award)
  3. 4 Open-market sale See Remarks sold 5,275 shares at $2.03 ($10,708)
  4. 4 Option exercise Director acquired 361,621 shares (option exercise)
  5. 4 Open-market buy Director bought 40,000 shares at $4.40 ($176,160)
  6. 4 Open-market sale See Remarks sold 2,968 shares at $4.87 ($14,457)
  7. 4 Open-market sale See Remarks sold 9,186 shares at $4.87 ($44,745)
  8. 4 Open-market sale See Remarks sold 5,275 shares at $4.87 ($25,695)
  9. 4 Open-market sale See Remarks sold 14,177 shares at $4.87 ($69,056)
  10. 4 Option exercise Director acquired 25,000 shares (option exercise)
  11. 4 Grant or award See Remarks acquired 1,605,769 shares (grant or award)
  12. 4 Grant or award See Remarks acquired 798,076 shares (grant or award)
  13. 4 Grant or award See Remarks acquired 432,692 shares (grant or award)
  14. 4 Grant or award See Remarks acquired 461,538 shares (grant or award)
  15. 4 Grant or award See Remarks acquired 115,384 shares (grant or award)
  16. 4 Open-market sale See Remarks sold 33,560 shares at $5.96 ($199,950)
  17. 4 Open-market sale See Remarks sold 15,498 shares at $5.96 ($92,337)
  18. 4 Open-market sale See Remarks sold 23,327 shares at an average $5.93 ($138,403)
  19. 4 Open-market sale See Remarks sold 81,017 shares at an average $5.94 ($481,320)
  20. 4 Open-market sale See Remarks sold 7,562 shares at $5.96 ($45,054)

Page 4 of 20 · 387 filings